Literature DB >> 25445428

Systematic detection of familial hypercholesterolaemia in primary health care: a community based prospective study of three methods.

Andrew B Kirke1, Rita A Barbour2, Sally Burrows3, Damon A Bell4, Alistair W Vickery2, Jon Emery5, Gerald F Watts6.   

Abstract

BACKGROUND: Familial hypercholesterolaemia (FH), a co-dominantly inherited disease of cholesterol that markedly increases risk of premature coronary artery disease (CAD), is significantly under-diagnosed. Primary health care is increasingly seen as a setting in which to increase the detection rate of index cases. We report a prospective study of three methods of case detection using pre-existing primary health care services in one community.
METHODS: Three methods of case detection were tested: pathology laboratory database search, workplace health checks and general practice database search. People identified at risk by each of the three screening methods were offered detailed assessment for FH using the Dutch Lipid Clinic Network Criteria score (DLCNCS).
RESULTS: 1316 participants underwent detailed assessment for FH. The proportion of at risk people identified for further assessment was in decreasing order: GP (659 of 2494, 26.4%), workplace assessment (60 of 268, 22.4%) and pathology database (597 of 4517, 13.2%) p<0.001. Eight-six (6.5%) were identified as clinical FH (DLCNCS>5) of which 59 had genetic testing and 11 of 59, 18.6%, were confirmed to have a mutation causing FH. Pathology database detected the greatest number of clinical FH (51 of 86, 59.3%) and mutation positive participants (8 of 11, 72.7%).
CONCLUSION: Screening within primary health care was successful in detecting participants with FH. An integrated case detection model combining screening of pathology and GP databases is proposed.
Copyright © 2014 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Case detection; Familial hypercholesterolaemia; General practice; Preventative cardiology; Primary health care; Screening

Mesh:

Year:  2014        PMID: 25445428     DOI: 10.1016/j.hlc.2014.09.011

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  13 in total

1.  Knowledge and Awareness of Familial Hypercholesterolaemia among Registered Medical Practitioners in Tamil Nadu: Are They Suboptimal?

Authors:  Nandhini Rangarajan; Shanthi Balasubramanian; Jing Pang; Gerald F Watts
Journal:  J Clin Diagn Res       Date:  2016-05-01

Review 2.  Strategies for screening for familial hypercholesterolaemia in primary care and other community settings.

Authors:  Nadeem Qureshi; Maria Luisa R Da Silva; Hasidah Abdul-Hamid; Stephen F Weng; Joe Kai; Jo Leonardi-Bee
Journal:  Cochrane Database Syst Rev       Date:  2021-10-07

3.  Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014).

Authors:  Emily M Bucholz; Angie Mae Rodday; Katherine Kolor; Muin J Khoury; Sarah D de Ferranti
Journal:  Circulation       Date:  2018-03-26       Impact factor: 29.690

4.  Improving detection and management of familial hypercholesterolaemia in Australian general practice.

Authors:  Tom Brett; Dick C Chan; Jan Radford; Clare Heal; Gerard Gill; Charlotte Hespe; Cristian Vargas-Garcia; Carmen Condon; Barbara Sheil; Ian W Li; David R Sullivan; Alistair W Vickery; Jing Pang; Diane E Arnold-Reed; Gerald F Watts
Journal:  Heart       Date:  2021-05-20       Impact factor: 5.994

5.  Feasibility of improving identification of familial hypercholesterolaemia in general practice: intervention development study.

Authors:  Nadeem Qureshi; Stephen Weng; Jennifer Tranter; Alia El-Kadiki; Joe Kai
Journal:  BMJ Open       Date:  2016-05-26       Impact factor: 2.692

6.  Detection and management of familial hypercholesterolaemia in primary care in Australia: protocol for a pragmatic cluster intervention study with pre-post intervention comparisons.

Authors:  Diane E Arnold-Reed; Tom Brett; Lakkhina Troeung; Alistair Vickery; Jacquie Garton-Smith; Damon Bell; Jing Pang; Tegan Grace; Caroline Bulsara; Ian Li; Max Bulsara; Gerald F Watts
Journal:  BMJ Open       Date:  2017-10-22       Impact factor: 2.692

7.  Validity and reliability of an adapted questionnaire measuring knowledge, awareness and practice regarding familial hypercholesterolaemia among primary care physicians in Malaysia.

Authors:  Ahmad Baihaqi Azraii; Anis Safura Ramli; Zaliha Ismail; Suraya Abdul-Razak; Siti Fatimah Badlishah-Sham; Noor Alicezah Mohd-Kasim; Norsiah Ali; Gerald F Watts; Hapizah Nawawi
Journal:  BMC Cardiovasc Disord       Date:  2021-01-19       Impact factor: 2.298

8.  Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care.

Authors:  Nadeem Qureshi; Ralph K Akyea; Stephen Weng; Joe Kai; Brittany Dutton; Jo Leonardi-Bee; Steve E Humphries
Journal:  Open Heart       Date:  2021-10

9.  Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales.

Authors:  Paul Crosland; Ross Maconachie; Sara Buckner; Hugh McGuire; Steve E Humphries; Nadeem Qureshi
Journal:  Atherosclerosis       Date:  2018-05-17       Impact factor: 5.162

10.  Screening and treatment of familial hypercholesterolemia in a French sample of ambulatory care patients: A retrospective longitudinal cohort study.

Authors:  Jean Ferrières; Victoria Banks; Demetris Pillas; Francesco Giorgianni; Laurene Gantzer; Beranger Lekens; Lea Ricci; Margaux Dova-Boivin; Jean-Vannak Chauny; Guillermo Villa; Gaelle Désaméricq
Journal:  PLoS One       Date:  2021-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.